Despite sustained declines in overall #CVD mortality in the U.S., disparities based on race, ethnicity & place still persist, with mortality varying far more across counties than states, according to a county-by-cause-by-population analysis. https://bit.ly/3UaTkUO

#JACC #GBDStudy #HealthEquity

🆕 ACC ECDP offers practical guidance for managing resistant #hypertension, from accurate BP measurement and diagnosis to treatment strategies, care teams, digital tools, and addressing barriers to care.

Get the details in #JACC: https://bit.ly/4yrBf3Z #BloodPressure #CardioSky

Breast cancer Tx can have lasting effects on CV health, making heart care essential to survivorship. This #BreastCancerAwarenessMonth, explore how #JACCCardioOnc advances cancer & CV care through research, expert perspectives & clinical insights. https://bit.ly/3ThPZmG #BreastCancerAwareness #BCsm

🆕 ACC Scientific Statement: A healthy, balanced dietary pattern, not individual nutrients or foods, is 🔑 to heart health. Emphasize minimally processed plant foods, healthy fats & proteins, while limiting refined starches, added sugars, sodium & unhealthy fats. https://bit.ly/46XHwYW #CVD #cvPrev

🆕 #JACCAdvances viewpoint: Dr. Ramzi Ibrahim reflects on the inaugural Fuster Prevention Forum & calls for a shift toward #cvPrev before pts reach a cardiologist. With risk beginning in childhood, he highlights the potential of early prevention to add decades of healthy life https://bit.ly/4jnVsTo

Pneumococcal bacteremia with encephalopathy should prompt early TTE and cerebrospinal fluid evaluation to identify Austrian syndrome and guide antimicrobial and source control decisions.

Get the details in #JACCCaseReports: https://bit.ly/4yGdvsi #ACCLATAM #CardioSky

Study finds that strength training does not increase risk of ventricular arrhythmia in patients with arrhythmogenic cardiomyopathy www.jacc.org/doi/10.1016/... @jaccjournals.bsky.social

#CVD is the leading medical cause of duty-related deaths among #TacticalAthletes, including military personnel, firefighters, law enforcement, EMS responders, astronauts & pilots.

🆕 ACC/AHA Scientific Statement addresses their unique CV risks & specialized care needs. https://bit.ly/3T7M0ZH #JACC

Air pollution, wildfire smoke & extreme heat are increasingly recognized as contributors to #CVD, even at levels once considered safe. The latest #JACC issue explores the evidence, CV risks & opportunities for prevention.

Read the full issue: https://bit.ly/4yceNLk #CardioSky

In a new edition of ACC's Cardiology Hour, Dr. Valentin Fuster & a panel of experts break down the top late-breaking clinical trials released during #ESCCongress, such as NOTION-4, SINGLE-AF, & more!

📽️: https://bit.ly/4zOTxNn @accintouch.bsky.social #JACC #CardioSky

In this exploratory randomized trial extension, no statistically significant difference in all-cause mortality was detected between #PCI and CABG. The broad 95% CI does not exclude a clinically meaningful advantage of either strategy. https://bit.ly/4y7OMgr

#ESCCongress #JACC #cvCABG #CardioSky

The Fifth Universal Definition of #cvMI released on behalf of a joint task force from ACC, ESC, AHA & WHF, provides a 🆕 clinical classification of MI based on pathophysiology, aligns w/ clinical evaluation of pts & incorporates objective diagnostic criteria. https://bit.ly/4xnn9zR #JACC #CardioSky

Patients with Loeys-Dietz syndrome may develop acute type A aortic dissection despite guideline-concordant surveillance & aortic dimensions below current surgical thresholds, highlighting the need for improved individualized risk stratification. https://bit.ly/4ycncP3

#ESCCongress #JACCCaseReports

Lepodisiran produced sustained reductions in OxPL-apoB and OxPL-apo(a) levels that correlated with Lp(a) lowering, supporting the biological rationale for the ongoing phase 3 outcomes trial, but not clinical benefit. https://bit.ly/3UiDsQ1

#ESCCongress #JACC #cvLipids #CardioSky

In #heartfailure patients with #LBBB, CSP-CRT was noninferior to BiV-CRT in reducing LVESV and both treatment modalities provided similar and excellent improvements in #LVEF, QRS duration, heart failure symptoms, and functional capacity. https://bit.ly/4cLejUg

#ESCCongress #JACCCEP #CardioSky

Stentless #PCI with DCB was frequently used in patients undergoing PCI for bypass graft lesions in Japan & was not associated with a significant difference in 1yr clinical outcomes compared with contemporary DES-based PCI strategies. https://bit.ly/4xtkGUP

#ESCCongress #JACCINT #ACCIntl #CardioSky

🔥 What had everyone talking on Day 2 of #ESCCongress 2026? #JACC Deputy Editor John A. Spertus, MD, MPH, FACC, and JACC Associate Editor Marc P. Bonaca, MD, MPH, FACC, share top takeaways from Munich.

▶️ Watch now: https://bit.ly/4y3qAMa

A protocol-based strategy for early intensive LLT significantly improved achievement of guideline-recommended LDL-C targets after ACS, supporting structured, algorithm-based lipid management in routine practice. https://bit.ly/4y96Gzn

#ESCCongress #JACC #cvACS #CardioSky

Nationwide study showed steady year-on-year rise in the age of pts undergoing #PCI, w/ no plateau. Older age was strongly assoc w/ worse outcomes, especially in nonagenarians, highlighting the need for shared decision-making in the oldest-old https://bit.ly/4gpOOKG

#ESCCongress #JACCAdvances #cvAMI

MAPLE-HCM: #Aficamten was superior to metoprolol regardless of baseline BB use or prior SOC therapy, supporting the primary results and suggesting no confounding by BB resistance. Aficamten may be considered an early treatment option. https://bit.ly/4qAJhnK

#ESCCongress #JACCHF #CardioSky #oHCM